Loading...
| Name | Option type | Quality (1-5)↓ | Topics | Created | |
|---|---|---|---|---|---|
Neumora stock recovers to pre-KOASTAL-1 levels by end of 2025?  | Binary | 3 | 8 days ago | ||
Navacaprant shows efficacy in women in KOASTAL-2 or KOASTAL-3 by end of 2025? | Binary | 2 | 8 days ago | ||
Neumora discontinues navacaprant development by end of 2025? | Binary | 2 | 8 days ago | ||
Outcome of KOASTAL-2 Phase 3 trial for navacaprant by end of 2025 | Categorical | 2 | 8 days ago | ||
Next major competitor to launch KOR antagonist drug by end of 2025 | Categorical | 2 | 8 days ago | ||
Neumora's next major strategic move by end of 2025 | Categorical | 2 | 8 days ago |